Masahiro Uehara

783 total citations
45 papers, 583 citations indexed

About

Masahiro Uehara is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Masahiro Uehara has authored 45 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 9 papers in Surgery. Recurrent topics in Masahiro Uehara's work include Wnt/β-catenin signaling in development and cancer (5 papers), Gastrointestinal disorders and treatments (4 papers) and Gastric Cancer Management and Outcomes (4 papers). Masahiro Uehara is often cited by papers focused on Wnt/β-catenin signaling in development and cancer (5 papers), Gastrointestinal disorders and treatments (4 papers) and Gastric Cancer Management and Outcomes (4 papers). Masahiro Uehara collaborates with scholars based in Japan, United States and Germany. Masahiro Uehara's co-authors include Toshinari Minamoto, Takahiro Domoto, Takayuki Kinoshita, Takashi Fukutomi, Takashi Hojo, Sadako Akashi‐Tanaka, Eriko Iwamoto, Katsuyoshi Miyashita, Takeo Shimasaki and Mitsutoshi Nakada and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Hepatology.

In The Last Decade

Masahiro Uehara

38 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masahiro Uehara Japan 12 276 150 118 108 82 45 583
Mingyuan He China 15 236 0.9× 98 0.7× 91 0.8× 154 1.4× 96 1.2× 38 589
F. Mihaimeed United Kingdom 5 332 1.2× 91 0.6× 105 0.9× 66 0.6× 53 0.6× 6 529
Guangyuan Song China 16 328 1.2× 153 1.0× 210 1.8× 161 1.5× 94 1.1× 47 621
Hengyu Li China 12 361 1.3× 145 1.0× 188 1.6× 98 0.9× 138 1.7× 32 736
Xiaofeng Li China 13 291 1.1× 247 1.6× 176 1.5× 143 1.3× 65 0.8× 57 683
Min Feng China 18 251 0.9× 240 1.6× 140 1.2× 126 1.2× 138 1.7× 31 803
Yang Lv China 13 262 0.9× 121 0.8× 158 1.3× 45 0.4× 64 0.8× 29 540
Feifei Jiang China 11 387 1.4× 172 1.1× 223 1.9× 57 0.5× 130 1.6× 31 726
Yifeng Tao China 14 190 0.7× 90 0.6× 105 0.9× 81 0.8× 92 1.1× 37 512

Countries citing papers authored by Masahiro Uehara

Since Specialization
Citations

This map shows the geographic impact of Masahiro Uehara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiro Uehara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiro Uehara more than expected).

Fields of papers citing papers by Masahiro Uehara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahiro Uehara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiro Uehara. The network helps show where Masahiro Uehara may publish in the future.

Co-authorship network of co-authors of Masahiro Uehara

This figure shows the co-authorship network connecting the top 25 collaborators of Masahiro Uehara. A scholar is included among the top collaborators of Masahiro Uehara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahiro Uehara. Masahiro Uehara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Uehara, Masahiro, Takahiro Domoto, Satoshi Takenaka, et al.. (2024). Glycogen synthase kinase 3β: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancer. Cancer Drug Resistance. 7. 4–4.
3.
Shirai, Toshihiro, et al.. (2024). Pulmonary cryptococcosis suspected due to inhalation of swallow excreta presenting with multiple infiltrative shadows. Respiratory Medicine Case Reports. 49. 102014–102014.
4.
Domoto, Takahiro, et al.. (2020). Glycogen Synthase Kinase 3β in Cancer Biology and Treatment. Cells. 9(6). 1388–1388. 81 indexed citations
5.
Uehara, Masahiro, Takahiro Domoto, Satoshi Takenaka, et al.. (2020). Glycogen synthase kinase‐3β participates in acquired resistance to gemcitabine in pancreatic cancer. Cancer Science. 111(12). 4405–4416. 9 indexed citations
6.
Imokawa, Shiro, Masahiro Uehara, Tomohiro Uto, Jun Sato, & Takafumi Suda. (2015). Organizing pneumonia associated with myeloperoxidase anti‐neutrophil cytoplasmic antibody. Respirology Case Reports. 3(4). 122–124. 6 indexed citations
7.
Imokawa, Shiro, Koji Nishimoto, Masahiro Uehara, et al.. (2011). A Case of Humidifier Lung: Possible Contribution of Gram-negative Bacteria and Fungi.. 31(1). 41–46. 1 indexed citations
8.
Uehara, Masahiro, Masanori Harada, Hiroshi Uchiyama, et al.. (2010). Clinicopathological Investigation of 5 Autopsy Cases of Pulmonary Pleomorphic Carcinoma. Haigan. 50(6). 803–808. 3 indexed citations
9.
Sakamoto, Katsunori, et al.. (2009). A CASE OF PERINEAL HERNIA AFTER A LAPAROSCOPIC ABDOMINOPERINEAL RESECTION. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 70(9). 2898–2901.
10.
Sakamoto, Katsunori, et al.. (2009). Ileum Penetration and Stenosis due to SMV Thrombosis treated by Elected Surgery. The Japanese Journal of Gastroenterological Surgery. 42(10). 1585–1590. 2 indexed citations
11.
Uehara, Masahiro, et al.. (2008). Gastric Wall Metastasis from Esophageal Carcinoma. Report of a Case. The Japanese Journal of Gastroenterological Surgery. 41(1). 41–45. 3 indexed citations
12.
Baba, Shinji, et al.. (2008). A CASE OF GASTROINTESTINAL STROMAL TUMOR OF LIVER METASTASES WITH SECONDARY RESISTANCE OF IMATINIB. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 69(11). 2952–2955.
13.
Uehara, Masahiro, Takayuki Kinoshita, Takashi Hojo, et al.. (2008). Long-term prognostic study of carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3 (CA 15-3) in breast cancer. International Journal of Clinical Oncology. 13(5). 447–451. 108 indexed citations
14.
Uehara, Masahiro, et al.. (2007). Isolated Right External Iliac Lymph Node Recurrence from a Primary Cecum Carcinoma: Report of a Case. Japanese Journal of Clinical Oncology. 37(3). 230–232. 11 indexed citations
15.
Takenaka, Atsushi, et al.. (2003). Case Report of Eosinophilic Enteritis with Intestinal Stricture Requiring Emergency Surgery.. The Japanese Journal of Gastroenterological Surgery. 36(1). 57–61.
17.
Masuda, Jun, et al.. (1990). Clinical study on drug fever without drug eruption.. 44(4). 430–435. 1 indexed citations
18.
Takagi, Hitoshi, Masahiro Uehara, Shoji Yamada, et al.. (1990). [Evaluation of non-surgical treatments of hepatocellular carcinoma--investigation of the cases with long and short survivals after treatment].. PubMed. 25(4). 757–69. 4 indexed citations
19.
Nagamine, Takeaki, Shuichi Saito, Shoji Yamada, et al.. (1990). [Clinical evaluation of serum biotin levels and biotinidase activities in patients with various liver diseases].. PubMed. 87(5). 1168–74. 2 indexed citations
20.
Takagi, Hitoshi, et al.. (1989). A case report of transcatheter arterial embolization of cholestatic type of hepatoma. Gastroenterologia Japonica. 24(3). 315–319. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026